CXCR4 was of particular interest because breast cancer cells expressing CXCR4 reportedly move to secondary sites in lung, liver, bone marrow or lymph nodes where the CXCR4 ligand, the chemokine CXCL12, is produced in at high levels16, 28. This evidence concerns the gene CXCL12 and breast cancer.